A Virginia resident alleges she lost her hair while being treated with Taxotere, but that it never grew back after chemotherapy was finished. In response, she has filed a Taxotere lawsuit alleging that she was not adequately warned about the risk of permanent alopecia.

The plaintiff, Tracey D., says she began treatment with Taxotere as part of her chemotherapy regimen in 2008. She suffered hair loss during treatment, which cancer patients generally expect is a risk.

However, after her chemotherapy was over, Tracey claims her hair loss persisted—a condition known as alopecia. According to Tracey’s Taxotere lawsuit, she was not adequately warned about the possibility that her Taxotere hair loss could be permanent.

The Taxotere lawsuit claims that this permanent side effect led to mental anguish, emotional distress, medical expenses, and loss of enjoyment of life, among other problems. The Taxotere lawsuit was filed on multiple counts, including failure to warn, negligence, fraudulent misrepresentation and concealment, fraud and deceit, and others.

Tracey filed her Taxotere lawsuit on July 25, 2017, in the U.S. District Court for the Eastern District of Louisiana, where much of the Taxotere litigation is taking place.

Basics of Taxotere

Taxotere (also known by the generic name docetaxel) is a chemotherapy drug manufactured by pharmaceutical giant Sanofi. Taxotere was first approved by the U.S. Food and Drug Administration (FDA) back in 1996, and has grown steadily more popular over the years.

Unfortunately, many patients treated with docetaxel drugs are being left with problems growing back their hair, or even permanent hair loss complications after chemotherapy treatment is over.

Hair loss, a condition also known as alopecia, is a common symptom associated with chemotherapy treatment. While hair loss is one of the most recognizable and even expected of chemotherapy side effects, and most patients going into chemotherapy are aware of this risk, they are often unaware that the condition may become permanent. Indeed, patients generally expect that their hair will grow back after chemotherapy is over.

However, some may be left with permanent hair loss after treatment with Taxotere, unable to grow their hair back at all. Others may have some hair return, but still have great difficulty growing their hair back, and it only grows in clumps or patches.

Filing a Taxotere Lawsuit Over Hair Loss

According to this Taxotere lawsuit and others like it, Sanofi either knew or should have known that their drug Taxotere was linked with permanent hair loss complications.

If you or someone you love has suffered from permanent hair loss after chemo treatment with Taxotere or another docetaxel medication, you may be able to gain some kind of financial compensation by joining a Taxotere lawsuit.

Filing a Taxotere lawsuit cannot take away the pain and suffering a cancer patient endures, or take away the effects of permanent alopecia after chemo, but it can help compensate for the financial expenses incurred by cancer treatment bills or even lost wages.

The Taxotere Lawsuit is Case No. 2:18-cv-02926-KDE-MBN, in the U.S. District Court for the Eastern District of Louisiana.